hiv seronegativity
Showing 1 - 25 of 42
HIV Incidence and Participation Retention in Pune, India
Completed
- HIV Infections
- HIV Seronegativity
-
Pune, IndiaNational AIDS Research Institute
Aug 25, 2022
HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)
Completed
- HIV Infections
- HIV Seronegativity
- MTP-PE/MF59
- Env 2-3
-
Rochester, New York
- +2 more
Oct 28, 2021
HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- HIV Seronegativity
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +1 more
Oct 28, 2021
HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (Env 2-3)
Completed
- HIV Infections
- HIV Seronegativity
- Env 2-3
-
Rochester, New York
- +2 more
Oct 26, 2021
HIV, Pregnancy, HIV Seronegativity Trial (MF59, rgp120/HIV-1 SF-2)
Withdrawn
- HIV Infections
- +2 more
- MF59
- rgp120/HIV-1 SF-2
- (no location specified)
Oct 28, 2021
HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC-HIV MN120TMG (vCP205)
-
Birmingham, Alabama
- +5 more
Oct 28, 2021
HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC(2)120(B,MN)GNP (vCP1452)
- +2 more
-
Long Beach, California
- +16 more
Oct 27, 2021
HIV, HIV Seronegativity Trial in United States (HIV p24/MF59 Vaccine, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein
Completed
- HIV Infections
- HIV Seronegativity
- HIV p24/MF59 Vaccine
- +3 more
-
Birmingham, Alabama
- +6 more
Oct 27, 2021
HIV, Pregnancy, HIV Seronegativity Trial in New Haven, Nashville (gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- +2 more
- gp160 Vaccine (MicroGeneSys)
-
New Haven, Connecticut
- +1 more
Oct 27, 2021
HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)
Completed
- HIV Infections
- HIV Seronegativity
- Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
- +3 more
-
Baltimore, MarylandJHU AVEG
Oct 27, 2021
HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC(2)120(B,MN)GNP (vCP1452)
-
Birmingham, Alabama
- +12 more
Oct 13, 2021
HIV, HIV Seronegativity Trial in Worldwide (ALVAC(2)120(B,MN)GNP (vCP1452), MN rgp120/HIV-1, ALVAC(2)120(B,MN)GNP (vCP1452) )
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC(2)120(B,MN)GNP (vCP1452)
- +3 more
-
Rio de Janeiro, Brazil
- +3 more
Oct 13, 2021
Patient Adherence, HIV Seronegativity Trial in Los Angeles, San Diego, Torrance (brief Motivational Interviewing)
Completed
- Patient Adherence
- HIV Seronegativity
- brief Motivational Interviewing
-
Los Angeles, California
- +4 more
Sep 9, 2021
HIV Seronegativity, Linkage Trial in Los Angeles, San Diego (T-POWr Intervention)
Completed
- HIV Seronegativity
- Linkage
- T-POWr Intervention
-
Los Angeles, California
- +1 more
Sep 9, 2021
Patient Adherence, HIV Seronegativity Trial in United States (SoC + iTab)
Completed
- Patient Adherence
- HIV Seronegativity
- SoC + iTab
-
Long Beach, California
- +3 more
Jun 18, 2020
PrEP Uptake, HIV Seronegativity Trial in San Diego (Informed Risk Score)
Completed
- PrEP Uptake
- HIV Seronegativity
- Informed Risk Score
-
San Diego, CaliforniaUniversity of California, San Diego
May 8, 2020
Screening Protocol for HIV Vaccine Studies
Completed
- HIV Seronegativity
- HIV Infections
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 4, 2019
HIV Seronegativity, HIV Preventive Vaccine Trial in Johannesburg, Klerksdorp, Cape Town (MVA-C + gp140/MF59, DNA-C2 + MVA-C,
Completed
- HIV Seronegativity
- HIV Preventive Vaccine
- MVA-C + gp140/MF59
- +2 more
-
Johannesburg, Gauteng, South Africa
- +2 more
Jun 19, 2019
Kaposi's Sarcoma, HIV, HIV Seronegativity Trial run by the NCI (Bevacizumab)
Completed
- Kaposi's Sarcoma
- +2 more
- Bevacizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 7, 2017
HIV Seronegativity, AIDS Vaccines Trial run by the NIAID (VRC-HIVDNA009-00-VP)
Completed
- HIV Seronegativity
- AIDS Vaccines
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Volunteers That Have Participated to Preventive HIV-1 Vaccine
Terminated
- HIV Infection
- HIV Seronegativity
-
Paris, FranceCIC Cochin Pasteur, hôpital Cochin
May 31, 2017
HIV, HIV Seronegativity Trial in Phnom Penh (Tenofovir DF)
Withdrawn
- HIV Infections
- HIV Seronegativity
- Tenofovir DF
-
Phnom Penh, CambodiaNCAHDS
Dec 13, 2016
HIV, Vitamin A Deficiency, HIV Seronegativity Trial (Vitamin A)
Completed
- HIV Infections
- +2 more
- Vitamin A
- (no location specified)
Dec 13, 2016
Long-Term Effects of HIV Exposure and Infection in Children
Completed
- HIV Infections
- HIV Seronegativity
-
Birmingham, Alabama
- +91 more
Oct 4, 2013
HIV Prevention Preparedness Study
Completed
- HIV Infections
- HIV Seronegativity
-
Chatsworth, South Africa
- +9 more
May 13, 2010